LAPAROSCOPIC PANCREATECTOMY - 11/09/11
Résumé |
Laparoscopy is still evolving in its approach to pancreatic disease. Although laparoscopic resection of malignant processes of the pancreas must be considered experimental and should be attempted only in the setting of approved protocols by institutional review boards, the use of laparoscopy in benign diseases is beginning to be explored. The approach to the retroperitoneal pancreas is not new. Two early reports by Meyer-Burg4 (1972) and Ishida et al3 (1981) and later reports by Salky et al6, 7 (1985, 1988) describe the use of laparoscopy in the approach to and diagnosis of pancreatic disease. The reader is encouraged to review these reports as background information to help understand the evolution of laparoscopic surgery in pancreatic disease. Inherent in the performance of laparoscopic surgery of the pancreas is the ability to access the retroperitoneum. In the era of therapeutic laparoscopy, Gagner et al1 and Petelin5 were early proponents of retroperitoneal access. Although their initial descriptions involved the adrenal gland, the approach was a precursor to laparoscopic pancreatic surgery.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Barry A. Salky, MD, Mount Sinai Medical Center, Division of Laparoscopic Surgery, Box 1103, 1 Gustave L. Levy Place, New York, NY 10029 |
Vol 76 - N° 3
P. 539-545 - juin 1996 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
